HIGHLIGHTS
- who: Alessandra Vultaggio from the Immunoallergology Unit, Department Medical-Geriatric, AOU Careggi, Brambilla, , Florence, Italy have published the paper: Biweekly Hizentra® in Primary Immunodeficiency: a Multicenter, Observational Cohort Study (IBIS), in the Journal: (JOURNAL)
- what: The study was approved by the Comitato Etico Area Vasta Centro; Azienda Ospedaliera Universitaria Careggi, Firenze; and the Ethics Committees of each study center and was conducted in accordance with the Declaration of Helsinki and the current regulations for observational studies.
SUMMARY
Primary immunodeficiency diseases (PIDs) are a heterogeneous group of chronic congenital disorders of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.